STOCKHOLM, Feb. 14, 2024 /PRNewswire/ -- Calliditas'
Year-end report for January - December
2023 will be published in Swedish and English on Wednesday
21 February 2024 at 07.00 a.m. CET.
A combined audio cast and telephone conference with the
opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée
Aguiar-Lucander and CFO Fredrik
Johansson, CMO Richard Philipson and President North America
Maria Törnsén.
The presentation will be given in English.
Link to the webcast:
https://ir.financialhearings.com/calliditas-therapeutics-q4-report-2023
To participate via conference call please register via this
link:
https://conference.financialhearings.com/teleconference/?id=50046870
After registration, you will receive a phone number and a
conference ID to log in to the conference call. Via the telephone
conference, there is an opportunity to ask oral questions.
For further information, please contact:
Åsa
Hillsten, Head of IR & Sustainability, Calliditas
Tel. +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact person set out above, on February 14, 2024, at 7:00
a.m. CET.
The following files are available for download:
https://mb.cision.com/Main/16574/3927985/2602135.pdf
|
Invitation to the
presentation of Calliditas_Q4 2023
|
View original
content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-calliditas-year-end-report-january--december-2023-302061418.html